Dianthus Therapeutics (NASDAQ:DNTH – Get Free Report) is expected to be issuing its quarterly earnings data before the market ...
Cantor Fitzgerald lifted their FY2025 EPS estimates for Dianthus Therapeutics in a research report issued on Thursday, March 13th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results